Enzolytics Inc (ENZC)

[falon]

Nobody is going to make money unless the company produce results.

It don't matter who has how many shares or what class of shares.

Bottom line is will the company do any of the following:

1. License agreements

2. Africa ITV-1 treatment success

3. Samsung Biologics Website: https://samsungbiologics.com/en Partnership

4. Scendea USA, Inc. (www.scendea.com) Partnership

5. IPF Immune(TM) revenue

6. SPAC deal with SAGA closes

7. Abveris, a division of Twist Bioscience Corporation https://www.abveris.com/ Partnership

8. Effectiveness of ITV-1 immunotherapy on Diabetes.

9. Clone 3
10. Development of Feline Leukemia Monoclonal Antibodies

11. Clone 7

12. Production Monoclonal Antibodies against HIV

13. Development Monoclonal Antibodies against the Corona Virus

14. Patents protection

15. AI

16. Advancing multiple therapeutics targeting numerous infectious diseases

Nobody knows what the outcome is going to be at the point and time.

The non-binding agreement was made.

The Business Combination Agreement was executed.

De-Spac process is moving forward to the closing of the project.


Will it be a Halloween Treat, an Early Bird Thanksgiving or a Very Merry Christmas?